| Product Code: ETC7683033 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Italy Sarilumab Market Overview |
3.1 Italy Country Macro Economic Indicators |
3.2 Italy Sarilumab Market Revenues & Volume, 2021 & 2031F |
3.3 Italy Sarilumab Market - Industry Life Cycle |
3.4 Italy Sarilumab Market - Porter's Five Forces |
3.5 Italy Sarilumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.6 Italy Sarilumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.7 Italy Sarilumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Italy Sarilumab Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.9 Italy Sarilumab Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Italy Sarilumab Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
4 Italy Sarilumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Italy |
4.2.2 Growing awareness and adoption of biologic therapies |
4.2.3 Favorable government regulations and policies supporting access to innovative treatments |
4.3 Market Restraints |
4.3.1 High cost associated with sarilumab treatment |
4.3.2 Limited reimbursement coverage for sarilumab in Italy |
4.3.3 Intense competition from other biologic therapies in the market |
5 Italy Sarilumab Market Trends |
6 Italy Sarilumab Market, By Types |
6.1 Italy Sarilumab Market, By End-Users |
6.1.1 Overview and Analysis |
6.1.2 Italy Sarilumab Market Revenues & Volume, By End-Users, 2021- 2031F |
6.1.3 Italy Sarilumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.1.4 Italy Sarilumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.1.5 Italy Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Italy Sarilumab Market, By Demographic |
6.2.1 Overview and Analysis |
6.2.2 Italy Sarilumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.3 Italy Sarilumab Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.3 Italy Sarilumab Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Italy Sarilumab Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.3.3 Italy Sarilumab Market Revenues & Volume, By Community-acquired Pneumonia, 2021- 2031F |
6.3.4 Italy Sarilumab Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Italy Sarilumab Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 Italy Sarilumab Market Revenues & Volume, By Antirheumatic, 2021- 2031F |
6.4.3 Italy Sarilumab Market Revenues & Volume, By Interleukin-6 Receptor Antagonist, 2021- 2031F |
6.4.4 Italy Sarilumab Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.5 Italy Sarilumab Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Italy Sarilumab Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.5.3 Italy Sarilumab Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 Italy Sarilumab Market, By Dosage |
6.6.1 Overview and Analysis |
6.6.2 Italy Sarilumab Market Revenues & Volume, By Injection, 2021- 2031F |
6.6.3 Italy Sarilumab Market Revenues & Volume, By Solution, 2021- 2031F |
7 Italy Sarilumab Market Import-Export Trade Statistics |
7.1 Italy Sarilumab Market Export to Major Countries |
7.2 Italy Sarilumab Market Imports from Major Countries |
8 Italy Sarilumab Market Key Performance Indicators |
8.1 Patient adherence rate to sarilumab treatment |
8.2 Number of new prescribers of sarilumab |
8.3 Patient satisfaction and quality of life improvements post sarilumab treatment |
9 Italy Sarilumab Market - Opportunity Assessment |
9.1 Italy Sarilumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.2 Italy Sarilumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.3 Italy Sarilumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Italy Sarilumab Market Opportunity Assessment, By Type, 2021 & 2031F |
9.5 Italy Sarilumab Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Italy Sarilumab Market Opportunity Assessment, By Dosage, 2021 & 2031F |
10 Italy Sarilumab Market - Competitive Landscape |
10.1 Italy Sarilumab Market Revenue Share, By Companies, 2024 |
10.2 Italy Sarilumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here